Pharmafile Logo
Pharmafocus logo
Advanced Search

SNG001

Showing 1 posts of 1 posts found.

Astrazeneca image

AstraZeneca signs $240m asthma deal with UK biotech

June 12, 2014
Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen

UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …

News
The Gateway to Local Adoption Series

Latest content

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026

Coriolis Pharma appoints Teun van der Heide as CEO

November 7, 2026